Gene: MTHFD1
Official Full Name: methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1provided by HGNC
Gene Summary: This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00548 | MTHFD1 gRNA3-gRNA4 KO plasmid | MTHFD1 | $850 | |||
KO00257 | MTHFD1 Knockout cell line (HEK293) | Human | MTHFD1 | 1:3~1:6 | Negative | Online Inquiry |
MTHFD1 Gene Knockout Cell Lines are genetically engineered cell lines designed to provide researchers with a tool for the functional analysis of the MTHFD1 gene, which encodes the 5,10-methylene tetrahydrofolate dehydrogenase enzyme involved in folate metabolism. By specifically knocking out this gene, these cell lines facilitate the study of metabolic pathways and provide insights into cellular responses that may be altered in pathological conditions.
The key function of the MTHFD1 Gene Knockout Cell Lines lies in their ability to disrupt the MTHFD1 pathway, leading to altered biosynthesis of nucleotides and amino acids, thereby affecting cell proliferation and differentiation. The knockout mechanism is achieved through techniques such as CRISPR/Cas9, which introduces precise mutations in the MTHFD1 locus, confirming gene disruption through sequencing and phenotypic assessments.
In scientific research and clinical settings, these knockout cell lines are pivotal for examining the role of MTHFD1 in diseases such as cancer, where aberrant folate metabolism contributes to tumorigenesis. Their application can extend to drug development, allowing for the identification of potential therapeutic targets and the assessment of compound efficacy.
The advantages of using MTHFD1 Gene Knockout Cell Lines include their high specificity and reproducibility compared to traditional methods, such as chemical inhibitors or RNA interference, which may produce off-target effects or variable responses. Furthermore, these cell lines offer researchers a robust platform for genetic studies, providing clear models that facilitate mechanistic studies regarding the role of MTHFD1 in various biological processes.
By integrating MTHFD1 knockout models into their research, scientists can enhance their understanding of folate metabolism in health and disease. Our company specializes in high-quality genetic models designed for advanced research applications, underlining our commitment to supporting the scientific community with reliable tools for exploration and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.